ERO Ero Copper Q4 2025 EPS narrowly misses analyst estimates as shares log slight gains Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval ECCW Eagle posts Q4 2025 earnings per share 138 percent above estimates shares trade flat today